NASDAQ:VVOS | Cash Flow Statement | Vivos Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.48M
2026-03-31-$7.68M-$6.01M$18,000.00-$18,000.00$6.11M
2025-12-31-$6.89M$442,000.00-$3.81M$1.53M-$1.58M$4.34M
2025-09-30-$5.4M
2025-06-30-$5.01M
2025-03-31-$3.86M$177,000.00-$3.8M$122,000.00-$122,000.00
2024-12-31-$2.83M$144,000.00-$2.94M$165,000.00-$165,000.00$3.05M
2024-09-30-$2.62M
2024-06-30-$1.93M
2024-03-31-$3.76M$146,000.00-$2.52M$151,000.00-$151,000.00$3.64M
2023-12-31-$4.26M$149,000.00-$2.75M$165,000.00-$165,000.00$3.57M
2023-09-30-$2.09M
2023-06-30-$5.53M
2023-03-31-$1.7M$175,000.00-$3.54M$239,000.00-$289,000.00$7.36M
2022-12-31-$6.09M$169,000.00-$3M$200,000.00-$200,000.00
2022-09-30-$5.43M
2022-06-30-$6.99M
2022-03-31-$5.33M$41,000.00-$6.08M$120,000.00-$120,000.00
2021-12-31-$7.39M$168,000.00-$4.12M$382,000.00-$382,000.00$0.00
2021-09-30-$5.45M
2021-06-30-$4.04M
2021-03-31-$3.4M$177,000.00-$3.86M$262,000.00-$262,000.00-$25,000.00
2020-12-31-$6.25M-$3.62M$94,989.00-$94,989.00$20.37M
2020-09-30-$1.81M
2020-06-30-$1.41M
2020-03-31-$2.58M-$436,910.00$5,204.00-$5,204.00$79,515.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$21.17M$1.31M-$15.26M$2.34M-$7.53M$18.56M
2024-12-31-$11.14M$581,000.00-$12.69M$568,000.00-$568,000.00$17.88M
2023-12-31-$13.58M$621,000.00-$11.95M$803,000.00-$853,000.00$10.92M
2022-12-31-$23.85M$669,000.00-$19.59M$924,000.00-$924,000.00
2021-12-31-$20.29M$733,000.00-$15.74M$2.4M-$2.61M$24.17M
2020-12-31-$12.06M-$5.68M$120,000.00-$120,000.00$23.54M
2019-12-31-$10.75M-$5.34M$175,599.00$86,223.00$4.47M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.